MANE: Held by 2 Biotech Hedge Funds (2026) | BiotechEdge

Catalysts Convergence Squeeze SignalsNEW Cash Runway Insiders M&A Research

Home›Companies›Veradermics, Inc (MANE)

Veradermics, Inc

MANE

Held by 2 specialist biotech funds

2 funds opened new positions. Next phase3 readout (VDPHL01): Feb 2026. Short interest: 9.0% of float.

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

4.0/10

2 funds opened new positions

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback

●●

No recent insider activity●●

Phase2 readout expected Aug 2026●●

Held by 2 specialist funds●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Conviction + Catalyst

2 specialist funds hold MANE with a Phase 2 in 102 days for VDPHL01 (Androgenetic Alopecia, AGA, Male Pattern Baldness)

+2 more upcoming catalysts

Deep Track Capital Deerfield Management

Fund Holdings

Deep Track CapitalNew

Deerfield ManagementNew

Short Interest

Short Shares

2.06M

Change

-11.2%

Days to Cover

3.0

% of Float

9.0%

Settlement

Apr 30, 2026

Short interest over 2 periods

Catalysts

Phase 3Q1 2026VDPHL01Androgenetic Alopecia, AGA, Male Pattern BaldnessNCT06724614

Phase 2Q3 2026VDPHL01Androgenetic Alopecia, AGA, Male Pattern BaldnessNCT06527365

Phase 3Q4 2026VDPHL01Androgenetic Alopecia, AGA, Male Pattern BaldnessNCT06972264

Phase 3Q2 2027VDPHL01 QDAndrogenetic Alopecia (AGA), Androgenetic Alopecia, AGANCT07146022

Be first to know when this name moves

Fund buys and exits, insider activity, and catalyst alerts across 800+ biotechs — free Monday brief.

Position Details

Deep Track CapitalNEW POSITIONMay 15, 2026

Start free trialfor share counts, dollar values & AI analysis

1 more position change — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

ACAD1 fund AHCO1 fund ALEC1 fund ALNY1 fund ANNX1 fund ARWR1 fund SPRY1 fund BLTE1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer